Previous 10 | Next 10 |
home / stock / ilmn / ilmn articles
U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Thursday. Shares of The J. M. Smucker Company (NYSE:SJM) rose sha...
Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the al...
U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index future...
Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER). "I think Uber is ...
In a setback for EU antitrust regulators, an adviser to Europe’s top court has criticized the decision to block Illumina Inc’s&nbs...
Activist investor Carl Icahn has opted against pursuing a fresh challenge to Illumina Inc’s (NASDAQ:ILMN) board, a move that spares...
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence ...
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigati...
News, Short Squeeze, Breakout and More Instantly...
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 11, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ:ILMN) previously announced on June 24 , the company will issue results for the second qu...
The Illumina iHope China program will provide 1800 families with genetic testing in 2024, broadening its reach and impact nationwide Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / July 11, 2024 / This year may be the most impactful yet in the short history o...
Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base PR Newswire Accessible, highly scalable single-cell technology expands Illumina's multiomics capabilities SAN DIEGO , July 9, 2024 /PRNews...